Clinical Trial Update: Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating hydroxychloroquine with FOLFIRI and bevacizumab in DTP-high metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Hydroxychloroquine (hydroxychloroquine)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING